Bayer AG (EUR)
BAYN
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
IndustryDrug Manufacturers - Major
Day Range65.86 | 67.16
52-Wk Range |
Last Close-
Mkt Cap (m)-
Dividend yield-
ISINDE000BAY0017
Volume3,410,664
Exchange VenueETR

Company Profile

Bayer AG is active in the German healthcare sector. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and animal health products.

Key Information
Price/Earning-
Price/Book-
Price/Sales-
P/CF-
Rev Growth (3 year avg)-5.10
EPS Growth (3 year avg)-0.29
Operating Margin % 0.82
Net Margin %4.28
Return on Equity4.10
Debt/Equity0.90

Legal Documents

Annual Report
en 31/12/2015

Financials

Income Statement
EUR201320142015201620172018
Revenue (m)40,15742,23946,32446,76935,01539,586
Operating Income (m)5,0145,7276,8037,3336,110323
Net Income (m)3,1893,4264,1104,5317,3361,695
Basic EPS3.864.144.975.448.411.80
Avg. Diluted Shares Outstanding (m)827827827833872905
Balance Sheet
EUR201320142015201620172018
Current Assets (m)19,02822,22723,82130,44730,07330,933
Non Current Assets (m)32,28948,00750,09651,79145,01495,352
Total Assets (m)51,31770,23473,91782,23875,087126,285
Current Liabilities (m)14,02315,50316,98018,53713,59322,823
Total Liabilities (m)------
Total Equity (m)20,71820,10624,26530,33336,80145,977
Cash Flows
EUR201320142015201620172018
Operating Cash Flows (m)5,1715,8106,8909,0898,1347,917
Capital Expenditure (m)-2,157-2,371-2,517-2,578-2,366-2,593
Figures are quoted in EUR unless stated otherwise
66.21
Last Price